Takeda Pharmaceutical Co Ltd
XBER:TKD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Takeda Pharmaceutical Co Ltd
XBER:TKD
|
JP |
|
L
|
Lime Technologies AB (publ)
F:LTX
|
SE |
|
Sword Group SE
PAR:SWP
|
LU |
|
Medexus Pharmaceuticals Inc
TSX:MDP
|
CA |
|
Philex Mining Corp
OTC:PXMFF
|
PH |
|
N
|
Novo Nordisk A/S
XMUN:NOV
|
DK |
|
C
|
Condor Gold PLC
TSX:COG
|
UK |
|
A
|
Adtalem Global Education Inc
DUS:DVY
|
US |
Wall St Price Targets
TKD Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for TKD is 29.41 EUR with a low forecast of 24.32 EUR and a high forecast of 37.92 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TKD's stock price target?
Price Target
29.41
EUR
According to Wall Street analysts, the average 1-year price target for TKD is 29.41 EUR with a low forecast of 24.32 EUR and a high forecast of 37.92 EUR.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 1%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 2 years is -5%.
What is the Net Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
44%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 3 years is 44%.
